Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5694894 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2017 | 17 Pages |
Abstract
Percentage of HCG increment in the 48Â h prior to methotrexate administration is an independent predictor for methotrexate treatment success. HCG increment <12% prior to methotrexate treatment is a good predictor for treatment success.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Aviad Cohen, Benny Almog, Yoni Cohen, Guy Bibi, Eli Rimon, Ishai Levin,